Fertility Outcomes and Sperm-DNA Parameters in Metastatic Melanoma Survivors Receiving Vemurafenib or Dabrafenib Therapy: Case Report.
BRAF inhibitors
cryopreservation
male fertility
metastatic melanoma
sperm DNA
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2020
2020
Historique:
received:
02
08
2019
accepted:
11
02
2020
entrez:
27
3
2020
pubmed:
27
3
2020
medline:
27
3
2020
Statut:
epublish
Résumé
Melanoma is a frequent neoplasm in young adult males in reproductive age, 10% of them degenerating into regional and/or distant metastases (MM). The use of BRAF inhibitors (BRAFi) vemurafenib and dabrafenib is effective in MM patients harboring
Identifiants
pubmed: 32211316
doi: 10.3389/fonc.2020.00232
pmc: PMC7066495
doi:
Types de publication
Case Reports
Langues
eng
Pagination
232Informations de copyright
Copyright © 2020 Ghezzi, Garolla, Magagna, Šabovich, Berretta, Foresta and De Toni.
Références
N Engl J Med. 2010 Aug 26;363(9):809-19
pubmed: 20818844
Oncotarget. 2017 Dec 7;9(3):3060-3068
pubmed: 29423028
J Endocrinol Invest. 2013 Jun;36(6):379-84
pubmed: 23047203
J Clin Pharmacol. 2014 Jun;54(6):696-706
pubmed: 24408395
Cancer Cell. 2004 Oct;6(4):313-9
pubmed: 15488754
Asian J Androl. 2015 Mar-Apr;17(2):236-8
pubmed: 25248651
Neoplasma. 2009;56(6):473-9
pubmed: 19728753
Nature. 2010 Sep 30;467(7315):596-9
pubmed: 20823850
J Clin Oncol. 2005 Sep 20;23(27):6771-90
pubmed: 16170185
J Dtsch Dermatol Ges. 2015 Apr;13(4):277-89; quiz 290
pubmed: 25819232
ESMO Open. 2019 May 23;4(3):e000491
pubmed: 31231568
Lancet. 2014 Oct 4;384(9950):1302-10
pubmed: 25283571
Lancet. 2010 Oct 16;376(9749):1301
pubmed: 20951890
Front Pharmacol. 2016 May 13;7:122
pubmed: 27242529
Cancer. 2012 Aug 15;118(16):4014-23
pubmed: 22180178
Andrology. 2017 Jul;5(4):711-717
pubmed: 28544654
Clin Cancer Res. 2017 Sep 15;23(18):5339-5348
pubmed: 28611198
Clin Cancer Res. 2014 Sep 1;20(17):4449-58
pubmed: 24958809
Nature. 2002 Jun 27;417(6892):949-54
pubmed: 12068308
Am J Mens Health. 2018 May;12(3):628-633
pubmed: 27489147
Nat Rev Clin Oncol. 2010 Aug;7(8):466-75
pubmed: 20498666
Int J Androl. 2011 Dec;34(6 Pt 2):e511-7
pubmed: 21790654
N Engl J Med. 2005 Nov 17;353(20):2135-47
pubmed: 16291983
N Engl J Med. 2009 Feb 26;360(9):902-11
pubmed: 19246362
J Am Acad Dermatol. 2016 Sep;75(3):528-534
pubmed: 27543212
Acta Oncol. 2018 Aug;57(8):1131-1133
pubmed: 29526130
Lancet. 2012 Jul 28;380(9839):358-65
pubmed: 22735384
Reprod Fertil Dev. 1995;7(4):799-809
pubmed: 8711214
Reprod Biomed Online. 2015 Jul;31(1):100-7
pubmed: 25985994
Andrology. 2017 Sep;5(5):898-904
pubmed: 28591464
Endocr Dev. 2009;15:101-134
pubmed: 19293606
Fed Regist. 2014 Dec 4;79(233):72063-103
pubmed: 25509060